TrialCancer discovery2024

Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer.

Minae An et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.